Immuron (IMRN) Research & Development (2016 - 2024)
Immuron (IMRN) recorded quarterly Research & Development of -$1296.2 billion in Q4 2024, down 48857378.76% quarter-over-quarter from -$2.7 million in Q4 2023, and down 48857378.76% on a YoY basis from N/an in Q1 2024.
Immuron (IMRN) Research & Development (2016 - 2024) Analysis & Trends
Immuron's Research & Development history runs 9 years deep, the most recent figure standing at -$1296.2 billion for Q4 2024.
- In Q4 2024, Research & Development fell 48857378.76% year-over-year to -$1296.2 billion; the TTM figure through Dec 2024 stood at -$1296.2 billion (down 32170104.05% YoY), while the FY2025 annual figure was $2.3 million, down 33.87% from the prior year.
- Research & Development was -$1296.2 billion for Q4 2024 at Immuron, down from -$2.7 million in the prior quarter.
- In the past five years, Research & Development ranged from a high of $148106.7 in Q2 2023 to a low of -$1296.2 billion in Q4 2024.
- Historically, Research & Development has averaged -$216.0 billion across 5 years, with a median of -$765270.4 in 2020.
- The sharpest annual moves came in 2021 and 2024: Research & Development jumped 69.81% in 2021, then sank 48857378.76% in 2024.
- A 5-year view of Research & Development shows it stood at -$8905.8 in 2020, then surged by 69.81% to -$2688.5 in 2021, then slumped by 56497.05% to -$1.5 million in 2022, then slumped by 74.36% to -$2.7 million in 2023, then tumbled by 48857378.76% to -$1296.2 billion in 2024.
- The last three Research & Development figures came in at -$1296.2 billion (Q4 2024), -$2.7 million (Q4 2023), and $148106.7 (Q2 2023), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | 4.32 Mn |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | 15.66 Mn |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 626,092.00 |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | -101.30 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | -2.30 Mn |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | 1.46 Mn |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | 357,444.00 |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 961.60 Mn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | -58.00 Mn |
| 10 | Immuron | 921.61 Mn | 921.58 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | -1,296.23 Bn |
| Dec 31, 2023 | -2.65 Mn |
| Jun 30, 2023 | 148,106.67 |
| Dec 31, 2022 | -1.52 Mn |
| Dec 31, 2021 | -2,688.54 |
| Dec 31, 2020 | -8,905.75 |
| Dec 31, 2019 | -7,614.21 |
| Dec 31, 2018 | -514,388.00 |
| Dec 31, 2017 | -1.20 Mn |
| Dec 31, 2016 | -1.60 Mn |
| Jun 30, 2016 | -2.71 Mn |